A detailed history of Ifm Investors Pty LTD transactions in Exact Sciences Corp stock. As of the latest transaction made, Ifm Investors Pty LTD holds 36,570 shares of EXAS stock, worth $2.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
36,570
Previous 38,008 3.78%
Holding current value
$2.1 Million
Previous $1.61 Million 55.14%
% of portfolio
0.02%
Previous 0.02%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$42.43 - $70.83 $61,014 - $101,853
-1,438 Reduced 3.78%
36,570 $2.49 Million
Q1 2024

Apr 22, 2024

BUY
$56.27 - $73.77 $7,090 - $9,295
126 Added 0.33%
38,008 $2.62 Million
Q3 2023

Oct 26, 2023

BUY
$65.94 - $99.04 $22,353 - $33,574
339 Added 0.9%
37,882 $2.58 Million
Q2 2023

Jul 27, 2023

BUY
$62.68 - $95.05 $389,117 - $590,070
6,208 Added 19.81%
37,543 $3.53 Million
Q1 2023

May 11, 2023

BUY
$47.19 - $70.77 $145,958 - $218,891
3,093 Added 10.95%
31,335 $2.12 Million
Q4 2022

Feb 14, 2023

BUY
$30.35 - $53.15 $76,542 - $134,044
2,522 Added 9.81%
28,242 $1.4 Million
Q1 2022

Apr 13, 2022

BUY
$57.56 - $82.54 $213,490 - $306,140
3,709 Added 16.85%
25,720 $1.8 Million
Q4 2021

Jan 18, 2022

BUY
$72.5 - $100.68 $26,172 - $36,345
361 Added 1.67%
22,011 $1.71 Million
Q3 2021

Oct 13, 2021

BUY
$90.24 - $124.05 $12,182 - $16,746
135 Added 0.63%
21,650 $2.07 Million
Q2 2021

Jul 16, 2021

BUY
$93.66 - $139.27 $333,710 - $496,219
3,563 Added 19.85%
21,515 $2.68 Million
Q1 2021

May 05, 2021

BUY
$116.57 - $155.01 $341,433 - $454,024
2,929 Added 19.5%
17,952 $2.37 Million
Q4 2020

Jan 13, 2021

BUY
$99.61 - $142.12 $306,300 - $437,019
3,075 Added 25.74%
15,023 $1.99 Million
Q3 2020

Oct 16, 2020

BUY
$72.92 - $102.01 $81,378 - $113,843
1,116 Added 10.3%
11,948 $1.22 Million
Q2 2020

Jul 13, 2020

SELL
$55.75 - $92.75 $185,982 - $309,414
-3,336 Reduced 23.55%
10,832 $942,000
Q1 2020

Apr 09, 2020

SELL
$37.9 - $104.44 $13,454 - $37,076
-355 Reduced 2.44%
14,168 $828,000
Q4 2019

Jan 13, 2020

SELL
$77.66 - $99.74 $5,358 - $6,882
-69 Reduced 0.47%
14,523 $1.34 Million
Q3 2019

Nov 01, 2019

BUY
$90.37 - $122.49 $582,796 - $789,938
6,449 Added 79.2%
14,592 $1.32 Million
Q2 2019

Jul 16, 2019

BUY
$89.51 - $118.04 $728,879 - $961,199
8,143 New
8,143 $961,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Ifm Investors Pty LTD Portfolio

Follow Ifm Investors Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifm Investors Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ifm Investors Pty LTD with notifications on news.